Related Experiment Video
Updated: Jan 20, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Hepatitis B Seroprotection in Pediatric Nephrotic Syndrome
Nischal Neupane1, Sriram Krishnamurthy2, Barath Jagadisan1
1Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Insights
Children with nephrotic syndrome have lower Hepatitis B seroprotection rates after vaccination. Steroid-resistant nephrotic syndrome is particularly associated with poor immune response to the Hepatitis B vaccine.
Area of Science:
- Pediatric Nephrology
- Immunology
- Vaccinology
Background:
- Nephrotic syndrome is a kidney disorder affecting children, often requiring immunosuppressive therapy.
- Hepatitis B vaccination is crucial for protection, but immune response can be affected by underlying conditions and treatments.
Purpose of the Study:
- To determine Hepatitis B seroprotection prevalence in vaccinated children with nephrotic syndrome.
- To compare seroprotection rates and antibody titers among nephrotic syndrome phenotypes.
- To assess the impact of immunosuppressive agents and proteinuria on Hepatitis B vaccine response.
Main Methods:
- Analyzed Hepatitis B serology and anti-HBs titers in 100 children with nephrotic syndrome (cases) and 100 healthy controls.
- Vaccination followed the Universal Immunization Program schedule.
- Compared seroprotection across different nephrotic syndrome phenotypes (steroid-sensitive, steroid-resistant) and controls.
Main Results:
- Seroprotection rates were significantly lower in children with nephrotic syndrome (37%) compared to controls (61%).
- Steroid-resistant nephrotic syndrome showed the lowest seroprotection rate (30%) compared to steroid-sensitive (40%) and controls (61%).
- A weak negative correlation was observed between proteinuria and protective anti-HBs titers.
Conclusions:
- Children with nephrotic syndrome exhibit diminished seroprotection following Hepatitis B vaccination.
- Steroid-resistant nephrotic syndrome is linked to a particularly inadequate immune response to the Hepatitis B vaccine.
- Proteinuria may play a role in reduced vaccine efficacy in this population.
Objective:
To study the prevalence of Hepatitis B seroprotection in children (>1 y) with nephrotic syndrome vaccinated against Hepatitis B vaccine as per the Universal Immunization Program schedule (0,6,10,14 wk); to compare the Hepatitis B seroprotection rates and anti-HBs titers among different phenotypes of nephrotic syndrome; to evaluate the association between Hepatitis B seroprotection status and the immunosuppressive agents; and to study the correlation between anti-HBs titres and proteinuria.
Methods:
Hepatitis B serology and anti-HBs titers were analyzed in 100 children (age-1-18 y) with different clinical phenotypes of nephrotic syndrome (cases) and 100 healthy controls.
Results:
The proportion of seroprotected children among the cases and controls was 37% (n=37) and 61% (n=61), respectively (P<0.04). The median (IQR) anti- HBs antibodies titers among the cases was 75 (62.5, 81) mIU/mL and 112 (56, 367) mIU/mL among the controls (P=0.001). The proportion of seroprotected children among the steroid sensitive nephrotic syndrome, steroid-resistant nephrotic syndrome and controls was 40% (n=28), 30% (n=9) and 61% (n=61), respectively (P<0.01). No differences in the anti-HBs titers between children receiving steroids versus steroids along with other immunosuppressants were found. Weak negative correlation was noted between proteinuria and protective titers (r = -0.155; P=0.039).
Conclusions:
Children with nephrotic syndrome, in general, and steroid-resistant nephrotic syndrome in particular, show poor seroprotection with Hepatitis B vaccination.
Related Concept Videos
Nephrotic Syndrome I : Introduction
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
09:44Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:02Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
